Pharmacy middlemen appear to be inflating drug prices, FTC says


9 July 2024 - The Federal Trade Commission released a critical report detailing how pharmacy benefit managers—like CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Group OptumRx, which manage 80% of American prescriptions—could be driving up the costs of some medications and favoring their own pharmacies at the expense of independent drug stores.

The FTC report said the market has become highly concentrated, as smaller companies were taken over by the nation’s largest health insurers and retail pharmacies, giving the managers significant power over access and pricing.

Read Forbes article 

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , Pharmacy